- Butorova LI, Tsibizova TA, et al. Exp Clin Gastroenterol. 2010;3:85-91.
- Albrecht M, Frerick H, et al. Z Klin Med. 1992;47:87-92.
- Gillessen A, Schmidt HH-J. Adv Ther. 2020;37(4):1279-1301.
- Post-White J, Ladas EJ, et al. Integr Can Ther. 2007;6(2):104-109.
- Legalon® 140 Cap 140 mg Package Insert: Version June 2024.
- Gundermann KJ, Kuenker A, et al. Pharmacol Rep. 2011;63(3):643-659.
- Niu W, Cao S, et al. Catalysts. 2017;7(8):238.
- Legalon 140 Cap 140mg Registration. Hong Kong Department of Health. Available at: https://www.drugoffice.gov.hk/eps/drug/productDetail/en/pharmaceutical_trade/145094. Accessed July 2024.
- Registration of Medicines in Hong Kong. Hong Kong Department of Health. Available at: https://www.dh.gov.hk/tc_chi/useful/useful_registration/useful_registration.html. Accessed August 2024.
- Song E, Kim JA, et al. Front Endocrinol (Lausanne). 2021;12:647459.
- Costa R, Mangini C, et al. Liver Int. 2023;43(3):534-545.
- Marti-Aguado D, Clemente-Sanchez A, et al. J Hepatol. 2022;77:191-205.
- Berná G, Romero-Gomez M, et al. Liver Int. 2020;40(Suppl. 1):102-108.
- Satapathy SK, Kuwajima V, et al. Ann Hepatol. 2015;14(6):789-806.
- Abenavoli L, Izzo AA, et al. Phytother Res. 2018;32:2202-2213.
- Mayo Clinic. Available at: https://shorturl.at/SBCFz. Accessed September 2024.
- Data on File. Viatris.
- Heyens LJM, Busschots D, et al. Front Med (Lausanne). 2021;8:615978.
- Cleveland Clinic. Available at: https://shorturl.at/3iMai. Accessed September 2024.
- Hallsworth K, Thoma C, et al. Frontline Gastroenterol. 2015;6(1):44-51.
- Kim JW, Park S, et al. Toxicol Res. 2014;30(2):65-70.
- Mukherji A, Bailey SM, et al. J Hepatol. 2019;71(1):200-211.
- Perez-Diaz-del-Campo N, Castelnuovo G, et al. Nutrients. 2022;14(23):5053.
- Liver Center. Available at: https://shorturl.at/VmCwa. Accessed September 2024.
- Liver Center. Available at: https://shorturl.at/Nokmo. Accessed September 2024.
- Healthline. Available at: https://shorturl.at/csHIT. Accessed Dec 2024.
- University Health News. Available at: https://shorturl.at/kBMSU. Accessed Dec 2024.
- The Healthy Liver. American Liver Foundation. Available at: https://shorturl.at/zKMZ7. Accessed Dec 2024.
# 根據一項涉及2,637名肝臟問題患者的臨床報告,當完成一個為期8週的水飛薊素療程後,一半肝臟問題患者的肝酵素指數 (ALT及AST) 回復正常。
^ 需配合均衡飲食及適量運動
產品成效和副作用因人而異,使用前請參閱產品包裝說明,詳情請向醫生或藥劑師查詢。